Stockreport

Plus Therapeutics Reports Third Quarter Financial Results and Recent Business Highlights [Yahoo! Finance]

PLUS THERAPEUTICS, Inc.  (PSTV) 
PDF Presented positive RESPECT-LM Ph1 clinical trial results HOUSTON, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), [Read more]